Archived Content

The content on this page is provided for reference purposes only. This content has not been altered or updated since it was archived.

Vaccines, Blood & Biologics

Product Approval Letter - August 14, 2008 - Component of Erytype S

August 14, 2008


Our STNs: Please see table below.


Biotest Medical Diagnostics GmbH
Attention: Dr. Rolf Vornhagen
Industriestrasse 1
D-63303 Dreieich


Dear Dr. Vornhagen:


We have approved your request to supplement your biologics license applications for the products listed below.


Our STNProduct Proper NameCell Line
BL 125097/10Blood Grouping Reagent, Anti-D (Monoclonal)(IgM)(Formulated for Automated Testing)BS226
BL 125097/10Blood Grouping Reagent, Anti-D (Monoclonal)(IgM)(Formulated for Automated Testing)BS232
BL 125098/8Anti-Human Globulin (Formulated for Automated Testing)N/A


Blood Grouping Reagent, Anti-D (Monoclonal)(IgM) (Formulated for Automated Testing) is used as a component of the Erytype® S Rh+K Type plate for Rh typing on the TANGO® optimo automated blood grouping and antibody test system.

Anti-Human Globulin (Formulated for Automated Testing) is used to detect sensitization of red blood cells on the TANGO® optimo system.

Any significance decrease in the reactivity or other changes in these products should be reported promptly to the Center for Biologics Evaluation and Research.

We will include information contained in the above-referenced supplements in your biologics license application files.

Sincerely yours,


/Elizabeth Callaghan/


Elizabeth Callaghan
Acting Director
Division of Blood Applications
Office of Blood Research and Review
Center for Biologics Evaluation & Research



Return to Blood Grouping Reagent - Component of Erytype S page

Resources for You

Page Last Updated: 03/17/2015
Note: If you need help accessing information in different file formats, see Instructions for Downloading Viewers and Players.
Language Assistance Available: Español | 繁體中文 | Tiếng Việt | 한국어 | Tagalog | Русский | العربية | Kreyòl Ayisyen | Français | Polski | Português | Italiano | Deutsch | 日本語 | فارسی | English